In terms of lung cancer diagnosis, what specific aspect does PET/CT help assess?

• A. Only tumor size.
• B. Staging and detecting metastasis.
• C. Response to treatment.
• D. Recurrence of cancer.

Answer: (B)

PET/CT plays a crucial role in the diagnosis and management of lung cancer, particularly in the staging and detection of metastasis. This imaging modality combines metabolic information from PET with anatomical details from CT, allowing for a comprehensive view of the tumor and potential spread throughout the body.

In lung cancer, accurate staging is essential for determining the extent of the disease, which directly influences treatment decisions and prognostic assessment. PET/CT helps identify the presence of metastatic disease by highlighting areas of increased metabolic activity that may represent cancer spread, which may not be visible on a CT scan alone. This capability allows clinicians to assess the lymph nodes and distant organs more effectively.

By detecting metastasis early, PET/CT not only contributes to better treatment planning but also impacts the patient's overall management and outcomes. For instance, if metastases are found, a different therapeutic approach may be warranted compared to localized tumors.

Thus, the specific aspect that PET/CT helps assess in lung cancer diagnosis is primarily focused on staging the disease and detecting metastasis, providing critical information for optimal patient care.